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Background: Acute otitis media (AOM) is one of the most common childhood infectious diseases. The recent
Italian Pediatric Guidelines for the treatment of AOM constitutes a step forward in the management of children
with uncomplicated AOM. The aim of this study was to evaluate antibiotic prescription patterns for AOM in a
Pediatric Emergency Department (PED) after those guidelines were introduced and to assess the relationship
between implementation of the “watchful waiting” strategy and the incidence of acute mastoiditis in the PED.
Methods: This retrospective study was conducted between 1st January 2007 to 31st December 2013 at the PED of
the University of Modena and Reggio Emilia in Modena (Italy). All children between 0 and 14 years who were
examined because of symptoms and/or signs of AOM and acute mastoiditis were enrolled. Pearson’s chi-squared
test was used to evaluate if introduction of the Italian Paediatric Guidelines was associated with a reduction in the
antibiotic prescription pattern in children with AOM and/or with an increase in mastoiditis frequency.
Results: 4,573 (89.4%) patients were included in our analysis, antibiotics were prescribed to 81% cases of the
children diagnosed with AOM. The frequency of antibiotic prescribing continued to be stable after the Italian
guidelines were introduced (82% versus 81%).
Forty children were admitted to hospital with a diagnosis of acute mastoiditis. Our study did not find any
association between the number of cases of acute mastoiditis and the percentage of patients treated with
antibiotics; the annual incidence of mastoiditis before and after the new guidelines were published was, in fact,
stable.
Conclusions: Despite the diffusion of clinical guidelines recommending a “watchful waiting” approach for children
with AOM, the antibiotic prescription rate continues to be high. It appears to be more difficult to impact the
percentage of cases for which antibiotics are prescribed than the type of antibiotic that is utilized. In view of these
findings, a close follow-up control by the primary care paediatrician or a scheduled follow-up appointment at the
PED and incisive campaigns to promote parents’ awareness of proper antibiotic use appear to be warranted.Background
Acute otitis media (AOM) is the most common disease
for which children receive antibiotics [1]. It has been cal-
culated that about 90% of children between the age of 3
months and 2 years experience an episode of AOM; the
peak incidence is between 6 and 12 months of age [1-6].
There has been much debate on the optimal treatment* Correspondence: silviapalma@inwind.it
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unless otherwise stated.for AOM and the prevention of complications. Inappro-
priate antibiotic treatment continues, moreover, to pose
a significant challenge in primary care [2,7]. While anti-
biotic resistance has become one of the world’s most
pressing public health problems, antibiotic prescription
rates for AOM are still high in most countries [8,9].
Most parents, nevertheless, perceive AOM to be a bur-
den for their child and families, particularly in view of
the pain and disturbed sleep associated to it [10].
“The observation option” treatment strategy that was
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who remain symptomatic for 72 hours is based on stud-
ies demonstrating that AOM heals spontaneously in 80%
of cases [11]. The Italian Pediatric Guidelines for AOM
diagnosis and prevention that were published in 2010
considered the 2004 Clinical Practice Guideline of the
American Academy of Pediatrics (AAP) as a model and
a starting point [12]. The Italian guidelines recommend
that “antibiotic treatment should be prescribed immedi-
ately for severe cases of AOM, for children younger than
two years with bilateral AOM, and cases of spontaneous
perforation. In all other cases, and in agreement with the
parents, it is possible to wait watchfully and to prescribe
antibiotic treatment only if the episode worsens or does
not improve within 48–72 hours. The main treatment of
earache is the systemic administration of appropriate
doses of analgesics (paracetamol or ibuprofen)” [12].
Amoxicillin was indicated in the guidelines as the first
choice drug in the case of AOM in children at low risk
of resistant pathogens [12].
Some have expressed concern, nevertheless, that the
observation strategy could lead to a higher rate of acute
mastoiditis, the most common severe complication asso-
ciated with AOM [5,6,9].
The principal objective of this study was to assess the
impact of the 2010 Italian guidelines on antibiotic pre-
scribing practice for this infection in the Paediatric
Emergency Department (PED) of the Paediatric Unit of
the University of Modena. The relationship between the
implementation of the watchful waiting policy and the
incidence of acute mastoiditis in the PED was also
evaluated.
Methods
This retrospective study was conducted between 1st
January 2007 to 31st December 2013 in the PED of the
Paediatric Unit of the University of Modena, an aca-
demic tertiary care pediatric medical center.
As this work represents an appraisal of PED practices
before and after Italian guidelines were introduced, an
institutional review board approval was not necessary.
All of the parents gave consent to collect and analyse
data contained in their children’s charts.
The key points contained in the Italian guidelines were
presented at educational meetings of the Pediatric Unit
involving all staff physicians. The entire document was,
moreover, freely accessible on the websites of the Italian
Society of Pediatric Otolaryngology (www.siop.it) and of
the Italian Society of Pediatrics (www.sip.it).
A trained staff physician screened the charts of the PED
for data on the children (aged 0 to 14 years) who were
possible candidates for inclusion in the study. “Acute otitis
media”, “otitis”, “otorrhea”, “earache”, “acute mastoiditis”
and “suspected mastoiditis” as the discharge diagnosiswere the search terms that were utilized. Children with
immunodeficiency, cranialfacial malformations, a history
of mastoiditis or ear surgery (i.e. tympanoplasty or coch-
lear implant) were excluded from the study as the guide-
lines are not applicable in these cases; children with
external otitis or whose final diagnosis differed from AOM
were excluded. All the charts in which the diagnosis was
not clear and any ambiguous data were clarified by discus-
sion between the otorhynolaryngologist and the senior
paediatrician and those charts were re-evaluated. The vari-
ables and the coding management of the search terms
were reviewed by other members of the staff.
All the children presenting at the PED were first evalu-
ated by a paediatrician using a static otoscope; in the
event of cerumen, otorrhea or in case of suspected\acute
mastoiditis, a consultation with an otolaryngologist was
requested. Once the diagnosis was made and treatment
was decided, the parents were instructed to consult their
family paediatrician within 24-48 hours for an appropriate
follow-up.
The information collected were: sex, age, discharge diag-
nosis (AOM or mastoiditis), type of management, and
type of antibiotics prescribed (when available). We catego-
rized the children’s ages into three classes: <2 years, be-
tween 2 and 6, older than 6. Depending on the type of
treatment recommended, the patients were divided into
three groups: children receiving no antibiotic prescription,
children receiving an antibiotic prescription, and children
receiving the recommendation to continue an antibiotic
that had already been prescribed. When the recommenda-
tion for the case was not registered, those patients were ex-
cluded from the analysis (7 cases). The data registered
before and after the publication of the Italian guidelines
(2007-2010 versus 2011-2013) were classified and analysed.
Categorical data were reported as absolute frequencies and
percentages. Pearson’s chi-squared test was used to evalu-
ate if publication of the Italian Paediatric Guidelines was
associated with a reduction in antibiotic prescriptions in
children with AOM and if the watchful waiting approach
was associated with an increase in mastoiditis. The analyses
were performed using STATA software v13, and a p-value
less than 0.05 was considered statistically significant.
Results
A total of 127,866 children were examined in the PED
during the study period; 5,115 of these were originally
considered eligible for inclusion (Figure 1). Out of that
group, 495 were excluded because the final diagnosis was
external otitis (438) or because of the presence of predis-
posing factors (57), and 7 were excluded because of lack of
knowledge about the treatment. Of the 4,580 patients who
were diagnosed with AOM at discharge, only 4,573
(89.4%) were included in our analysis (Figure 1). Fifty-six
percent of the children with AOM included in the analysis
Figure 1 Flowchart of the records of patients examined between 2007 and 2013.
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and 15% were older than six.
Excluding 14 children who were already receiving an
antibiotic before presenting at the PED, antibiotics
were prescribed to 81% cases of the children diagnosed
with AOM (Table 1). Analysis of the data revealed that
the percentage of antibiotic prescriptions did not vary
significantly after the Italian guidelines were intro-
duced (Table 1). The annual antibiotic prescription
rate in each age class was likewise analysed and no
statistical differences between pre and post rates were
found (Table 1).Table 1 Antibiotics prescribed before and after the guideline
Before the guide
introduced (n = 2
Period 2007- 2010
Antibiotics prescribed, n (%) 2,201 (82%)
Amoxicillin, n (%) 716 (33%)
Amoxicillin–clavulanate, n (%) 1,131 (51%)
Cefuroxime axetil, n (%) 235 (10%)
Macrolides, n (%) 48 (2%)
Antibiotics prescribed in the various age classes
<=2, n (%) 1,135 (86%)
2-6, n (%) 790 (77%)
> = 6, n (%) 276 (78%)The most frequently prescribed antibiotic was
amoxicillin-clavulanate (51%) and its distribution rate was
similar before and after the Italian Guidelines were
published (Table 1).
Forty children were admitted to the hospital with a diag-
nosis of acute mastoiditis over the study period (40/4,580
= 0.9%): 21 (52.5%) between 2007-2010 and 19 (47.5%) be-
tween 2011-2013 (Figure 2). Of these, 32.5% were younger
than 2 years. In 23 cases (58%) the children had received
antibiotic treatment before presenting at the PED. Antibi-
otics were not prescribed in 43% of the cases of acute
mastoiditis before the Italian guidelines were published;s were published
lines were
,692)
After the guidelines were




1,507 (81%) 3,708 (81%)
479 (32%) 1,195 (32%)
755 (50%) 1,886 (51%)
159 (11%) 394 (11%)
39 (3%) 87 (2%)
731 (84%) 2,184 (48%)
540 (78%) 1,715 (38%)
236 (77%) 660 (14%)
Figure 2 The distribution of mastoiditis across age classes before
and after the guidelines were published.
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the difference was not statistically significant. The mean
number registered per year was 6 cases (min-max = 4-7 in
2009 and 7 in 2013). When the number of mastoiditis
cases and the annual antibiotic prescription rate was
analysed, no relevant difference was found (Table 2).
Discussion
The principal objective of this study was to assess the
impact of the Italian Guidelines for the clinical man-
agement of AOM in a hospital setting. To our know-
ledge, this is the first study that has analysed antibiotic
prescribing patterns for AOM in patients admitted to
an Italian PED. The results demonstrate that a large
number of children are still evaluated in a PED for
AOM and that the watchful waiting strategy is still far
from routine use [13].
According to clinical activity databases, in most coun-
tries in which there are national guidelines for the man-
agement of AOM, adherence to the guidelines has been
poor [9]. Our study found a stable percentage in antibiotic
use in the periods before and after the Italian guidelines
were introduced in all age classes. We had expected to see
a high, stable percentage of antibiotic prescriptions only in
very young children as AOM is most frequent in infants
between 6 and 13 months of age [14]. These findings
could be explained if patients presenting at the PED afterTable 2 Patients presenting at our Pediatric Emergency Servi
Year Number of patients presenting
at the PED
Number (%) of patients wit
Acute Otitis Media
2007 17471 638 (3.7)
2008 18164 812 (4.5)
2009 18036 629 (3.5)
2010 17660 620 (3.5)
2011 18525 634 (3.4)
2012 18975 636 (3.4)
2013 19035 604 (3.2)the guidelines were introduced had more complex prob-
lems with respect to those seen in the past.
It is also possible that parents decide to take their chil-
dren to the PED in the event that symptoms persist once
a watchful waiting strategy has been prescribed by the
family paediatrician. While AOM has a low priority at a
PED and waiting times can be lengthy, many parents
are, nevertheless, very concerned about the infection
and the impact it can have on the child’s health. Fear
about the adverse consequences of the infection seems
to be the main obstacle to implementing the guidelines.
Staff paediatricians in the emergency room are probably
not convinced that the watchful waiting strategy is an
appropriate option for a PED setting and doubts linked
to patient follow-up may lead to more cautious thera-
peutic approaches [15].
As an accurate otological examination is critical for dis-
ease recognition, an uncertain diagnosis can also justify
the high rate of antibiotic prescription. The initial choice
of treatment may also be based on the general impact that
the disease produces in each individual patient [16]. Par-
ticular attention must, of course, be dedicated to the
child’s clinical condition and to such factors as age, signs
and symptoms as well as parents compliance: parents who
are uninformed about why appropriate use of antibiotics is
so important may be resistant to the watch and see guide-
line [10,17]. One study recently demonstrated that a
watchful waiting policy with and without a prescription of
antibiotics was tranquilly accepted by both groups of par-
ents of children diagnosed with AOM in an urban PED
[18]. This finding confirms that parents can accept this ap-
proach if they are provided appropriate explanations.
The objective of containing antibiotic-resistance is one
of the aims of the guidelines, an aim that should be
shared by physicians and parents alike, and the judicious
use of antibiotics remains the key to an optimal manage-
ment to prevent the complications of acute otitis media.
The risk of increasing multi-drug-resistant bacteria is
well known. Our study showed that the majority of children
attending our PED, regardless of age, were prescribed
broad–spectrum antibiotics such as amoxicillin-clavulanic
acid and cefuroxime. But similar studies have demonstratedce (PED) between 2007 and 2013
h Number (%) of patients with Acute
Otitis Media prescribed antibiotics
Number (%) of patients
with Acute Mastoiditis
513 (80.4) 5 (0.03)
656 (80.8) 6 (0.03)
535 (85.1) 4 (0.02)
497 (80.2) 6 (0.03)
495 (78.1) 6 (0.03)
522 (82.1) 6 (0.03)
490 (81.1) 7 (0.03)
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under the pressure of new recommendations; this means
that every effort to follow to the guidelines should continue
to be made [19-21].
Acute mastoiditis is the most common severe compli-
cation associated with AOM in younger children, but
some epidemiologic studies have shown that a universal
antibiotic therapy strategy in all cases of AOM cannot
be considered a valid way to reduce its risk. While the
watchful waiting policy seems to lead to only 1 to 2 extra
cases per 100,000 children per year, several studies have
concluded that the number of children who would need
to be treated to prevent this complication is too high
and that this strategy could pose a larger public health
problem in terms of antibiotic resistance [7,22-24]. Our
study did not find any association between the number
of cases of acute mastoiditis and the percentage of pa-
tients treated with antibiotics, as the annual rate was
found to be stable before and after the new recommen-
dations were published. As the results of some studies
appear to be contradictory, it is impossible to draw clear
conclusions [25,26]. Finnbogado’ttir, for example, con-
cluded there might be a correlation between reduced
antibiotic usage in children in Iceland and an increasing
incidence of mastoiditis following changes in the guide-
lines for antibiotic prescriptions for AOM in that country;
another study carried out in Sweden found no increase
after new guidelines were introduced [25,26].
We found a stable percentage of antibiotic usage also in
the children between 2 and 6, a group in which there was
an increase in the number of cases of acute mastoiditis.
Forty-two percent of the children who were diagnosed
with acute mastoiditis after the guidelines were published
were not prescribed antibiotic treatment. Prospective
studies could help to elucidate if these findings could be
the result of misdiagnosis.
Despite the fact that anatomical and physiological rea-
sons make children younger than 2 more susceptible to
AOM, only 32% of the children in that age bracket in
the Netherlands presented this complication [27]; in
Sweden there was an increase in acute mastoiditis only
in children younger than 2 in whom antibiotics were still
recommended in all cases of AOM [26].
The limitations of our study include its retrospective
design which does not permit an accurate assessment of
illness severity/duration and does not provide follow-up
data. Management of missing data can also pose meth-
odological problems. In addition, while our research was
made using appropriate key words, we cannot exclude
that a few cases might have been missed. Data registered
by paediatricians on staff may vary in detail and accuracy.
Another possible referral bias could be linked to sicker pa-
tients with persistent symptoms who are frequently taken
to the PED.Adherence to the guidelines could probably be en-
hanced if effective information campaigns were imple-
mented. In addition, the watchful waiting approach would
probably be utilized more frequently if, at discharge time,
parents were given an appointment for a check-up.
Conclusions
Despite the introduction of clinical guidelines that rec-
ommend a watchful waiting approach for children with
AOM, antibiotic prescribing rates in an Italian PED are
still high. It appears to be more difficult to impact the
percentage of cases for which antibiotics are prescribed
than the type of antibiotic that is utilized. In view of
these findings, a close follow-up control on the infec-
tion’s progression and incisive campaigns to promote
parents’ awareness of proper antibiotic use appear more
than warranted.
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